Insider Shareholders with Direct Ownership of Xilio Therapeutics, Inc. (XLO)
This section provides a comprehensive overview of the insiders with direct ownership of Xilio Therapeutics, Inc. (XLO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Xilio Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Gilead Sciences Inc
> 10% Shareholder |
2,245,228 | 0 | 9,105,451 $10.8 Million | 2 |
Dec 18, 2024
Added 16.2%
|
|
Sv7 Impact Medicine Fund Lp
> 10% Shareholder |
1,301,132 | 0 | 1,301,132 $1.55 Million | 1 |
Oct 26, 2021
Added 18.87%
|
|
Rene Russo
PRESIDENT AND CEO |
44,250 | 0 | 244,883 $291,410 | 1 |
Jan 01, 2025
Added 15.3%
|
|
Alexandria Venture Investments, Llc
> 10% Shareholder |
166,423 | 0 | 166,423 $198,043 | 1 |
Oct 26, 2021
Added 50.0%
|
|
Katarina Luptakova
CHIEF MEDICAL OFFICER |
16,625 | 0 | 16,625 $19,783 | 1 |
Jan 01, 2025
Added 50.0%
|
|
Christopher James Frankenfield
Chief Financial Officer |
19,375 | 6,954 | 12,421 $14,780 | 2 |
Jan 02, 2025
Reduced 35.89%
|
|
Kevin M. Brennan
SVP, FINANCE AND ACCOUNTING |
5,000 | 1,803 | 3,197 $3,804 | 2 |
Jan 02, 2025
Reduced 36.06%
|
|
Atlas Venture Fund Xi, L.P.
> 10% Shareholder |
0 | 3,839 | 0 $0 | 3 |
N/A
|